SARS-CoV-2 Research

Filter

SARS-CoV-2 Research


At present, the outbreak of a coronavirus-associated acute respiratory disease called coronavirus disease 19 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the third time that animal coronavirus has spread to human in just 20 years, leading to a major epidemic. As the virus continues its global spread, understanding the SARS-CoV-2 mechanism is critical for drug discovery and vaccine development. Relying on the recombinant virus development platform in our gene therapy service, Creative Biolabs launched tools for SARS-CoV-2 research including pseudoviruses and recombinant overexpressed viruses.

SARS-CoV-2 Research

Background of SARS-CoV-2 Infection

Since December 2019, in a city of 11 million people in Wuhan, China, more and more patients with unexplained pneumonia have alarmed local hospitals. The pathogenic factor was not discovered until January 7, 2020: SARS-CoV-2. The isolation and identification of the virus significantly promoted the development of molecular diagnostic methods and the identification of infected persons. The virus particles of SARS-CoV-2 look like a corona: the virus particles are spherical and have a certain polymorphism; the diameter of the virus particles is 60-140 nm, with obvious spikes, and the length is 8-12 nm. The morphological characteristics of SARS-CoV-2 are consistent with the typical characteristics of Coronaviridae.

Tools to Study SARS-CoV-2-Host Interactions

SARS-CoV-2 is a positive-stranded single-stranded RNA virus composed of several key proteins, including a spike (S) protein, a hemagglutinin esterase dimer (HE), a membrane (M) glycoprotein, an envelope (E) protein and a nucleocapsid (N) protein to promote infection. The S protein binds to the host angiotensin-converting enzyme 2 (ACE-2) receptor to mediate the virus into the host cell, thereby fusing the viral membrane to the host membrane. At present, many studies are focused on a better understanding of the interaction between the S protein of SARS-CoV-2 and the ACE-2 receptor, so as to better develop anti-infection strategies.

Postulated mechanisms modulating SARS-CoV-2 attachment and fusion machinery on human host cells.Fig.1 Postulated mechanisms modulating SARS-CoV-2 attachment and fusion machinery on human host cells. (Perrotta, 2020)

The Role of Recombinant Virus in SARS-CoV-2 Research

Through the use of recombinant DNA technology, recombinant viruses can be produced and modified in specific virus vectors, which can effectively transfer and promote a high level of transgenic expression in a variety of host cells. Relying on our extensive experience in the recombinant virus platform, we have developed two products to help researchers in the research of SARS-CoV-2.

Pseudoviruses have the basic components of cell entry and virus infection, but they lack nucleic acids and lose the ability of self-replication. Due to their safety and versatility, they are considered to be effective virology tools that can be used to imitate SARS-CoV-2 for further research.

Targeted overexpression of disease-causing genes through recombinant viral vectors provides a new and highly flexible method for the research and modeling of SARS-CoV-2 infection.

Creative Biolabs provides high-quality and different types of recombinant viruses that can be used in SARS-CoV-2 research. We strictly check and verify every step of recombinant virus production to ensure its reliability.

Reference

  1. Perrotta, F.; et al. Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter. Respiratory Medicine. 2020: 105996.

For Lab Research Use Only, Not for Human or Animal Therapeutic Use.

Interested in our expertise?

Contact us for more information

Get free consultations

USA

  • Tel:
  • Email:

Europe

Easy access to products and services you need from our library via powerful searching tools

Enter your email here to subscribe.

Submit

Follow us on

For Lab Research Use Only, Not for Human or Animal Therapeutic Use.

Copyright © 2021 Creative Biolabs. All Rights Reserved.